Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rosenberg, David
ABNCoV2-03, NCT05329220 / 2021-005504-36: ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2	Completed	3	4223	Europe, US	ABNCoV2, Comirnaty	Bavarian Nordic	COVID-19 Disease	03/23	10/23
REGEN-BRAIN©, NCT04838301: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease	Recruiting	2	200	US	Allopregnanolone, Allo, Placebo	University of Arizona, National Institute on Aging (NIA), Syneos Health, University of Southern California, ADM Diagnostics	Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases	04/25	12/26
Henry, Melissa
No trials found